| Basics |
Tandem Diabetes Care, Inc.
Tandem Diabetes Care Inc is a provider of medical care devices in the United States. Its products aid in the delivery of insulin and getting accurate readings through its software application.
|
| IPO Date: |
December 1, 2013 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$1.42B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.95 | 2.78%
|
| Avg Daily Range (30 D): |
$0.55 | 3.16%
|
| Avg Daily Range (90 D): |
$0.45 | 3.10%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.94M |
| Avg Daily Volume (30 D): |
1.94M |
| Avg Daily Volume (90 D): |
1.89M |
| Trade Size |
| Avg Trade Size (Sh.): |
85 |
| Avg Trade Size (Sh.) (30 D): |
74 |
| Avg Trade Size (Sh.) (90 D): |
73 |
| Institutional Trades |
| Total Inst.Trades: |
6,786 |
| Avg Inst. Trade: |
$2.77M |
| Avg Inst. Trade (30 D): |
$3.26M |
| Avg Inst. Trade (90 D): |
$2.7M |
| Avg Inst. Trade Volume: |
.06M |
| Avg Inst. Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$4.88M |
| Avg Closing Trade (30 D): |
$4.3M |
| Avg Closing Trade (90 D): |
$3.57M |
| Avg Closing Volume: |
107.04K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-3.03
|
$-.31
|
$-.78
|
|
Diluted EPS
|
$-3.03
|
$-.31
|
$-.78
|
|
Revenue
|
$ 1.01B
|
$ 249.25M
|
$ 240.68M
|
|
Gross Profit
|
$ 536.01M
|
$ 134.29M
|
$ 125.86M
|
|
Net Income / Loss
|
$ -203.37M
|
$ -21.17M
|
$ -52.4M
|
|
Operating Income / Loss
|
$ -196.13M
|
$ -22.86M
|
$ -51.81M
|
|
Cost of Revenue
|
$ 470.99M
|
$ 114.96M
|
$ 114.82M
|
|
Net Cash Flow
|
$ 42.91M
|
$ 27.84M
|
$ 10.54M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Oct 10, 2017:
1:10
|
|
|
|
